静脉注射免疫球蛋白作为治疗严重或类固醇复发性多形红血症的主要疗法:一个病例系列
Simone Mo1, Jennifer Nguyen1, Charlie Y Wang1
1Department of Dermatology, Monash Health, Clayton VIC, Australia.
Clinical and experimental dermatology
|February 26, 2026
概括
静脉注射免疫球蛋白 (IVIg) 显示出治疗严重多形红斑主要 (EM主要) 的前景,即使对类固醇有抗性. 这种治疗在一小群患者中耐受性良好且有效.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 大型多形红斑 (EM大) 可以导致严重的疾病,缺乏确定的治疗指南.
- 静脉注射免疫球蛋白 (IVIg) 通常用于复发性EM.
- 这项研究调查了IVIg对于严重的,第一集的,或类固醇耐火性EM大.
研究的目的:
- 评估IVIg在患有严重EM大病的患者的疗效和安全性.
- 评估IVIg在系统性皮质类固醇耐药病例中的作用.
- 为了确定严重的EM大发的潜在触发因素.
主要方法:
- 六名EM重症患者在澳大利亚一家高等医院接受IVIg治疗的回顾性分析.
- 在入院四天内,IVIg在八个实例中进行了管理.
- 对疾病触发因子的审查,包括Mycoplasma pneumoniae和SARS-CoV-2.
主要成果:
- 所有患者都对IVIg治疗显示出完全的反应.
- 平均改善时间为4.75天.
- IVIg耐受性良好,没有报告任何重大不良事件.
结论:
- IVIg在严重或耐皮质类固醇耐药的大型EM中显示出有效性和耐受性.
- 需要进一步的研究来证实这些发现并建立基于证据的指导方针.
- 在这个群体中,发现了严重的EM主要的潜在触发因素.
更多相关视频
相关概念视频
Myocarditis III: Medical Management
266
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Nephrotic Syndrome II : Assessment and Medical Management
279
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
279
Myocarditis IV: Nursing Management
297
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
297
Nephrotic Syndrome III : Nursing Management
398
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
398
Endocarditis III: Medical Management
291
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
291
Acute Kidney Injury IV: Diagnostic Studies and Prevention
387
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
387


